Literature DB >> 8148498

Flow cytometric analysis of surface membrane proteins on activated platelets and platelet-derived microparticles from healthy and thrombasthenic individuals.

S Nomura1, Y Komiyama, T Murakami, A Funatsu, T Kokawa, T Sugo, M Matsuda, K Yasunaga.   

Abstract

We used flow cytometry to investigate surface membrane protein expression by platelets and platelet-derived microparticles from normal individuals and a patient with Glanzmann's thrombasthenia. Microparticles were detected by both forward scatter and side scatter using FACScan. The binding of coagulation factors on microparticles was investigated by using monoclonal anti-Factor IX (IXa) and anti-Factor X (Xa) antibodies. Furthermore, the procoagulant activity of microparticles was measured with a chromogenic substrate (S-2222) using a microtiter enzyme-linked immunosorbent assay. Both types of platelets showed similar release of microparticles. Microparticles released from platelets after activation with the calcium ionophore A23187 did not bind factors IXa and Xa, but when purified factors Va and Xa were added to the incubation buffer, factor Xa binding increased markedly in both normal and thrombasthenic platelets. Both normal and thrombasthenic platelets showed a similar time-dependent release of microparticles when activated with A23187. However, the binding of an antibody to granule membrane protein-140 also increased time-dependently in normal microparticles, but was little increased in thrombasthenic microparticles. These findings suggest that glycoprotein IIb/IIIa does not participate in the expression of prothrombinase activity on the surface of activated platelets and microparticles, whereas this glycoprotein appears to have an important role in the movement of granule membrane protein-140 from platelets to microparticles.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8148498

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  3 in total

1.  Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

Authors:  J C Reverter; S Béguin; H Kessels; R Kumar; H C Hemker; B S Coller
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

Review 2.  Extracellular Vesicles as Drivers of Immunoinflammation in Atherothrombosis.

Authors:  Rosa Suades; Maria Francesca Greco; Teresa Padró; Lina Badimon
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

Review 3.  Microvesicles in Atherosclerosis and Angiogenesis: From Bench to Bedside and Reverse.

Authors:  Lina Badimon; Rosa Suades; Gemma Arderiu; Esther Peña; Gemma Chiva-Blanch; Teresa Padró
Journal:  Front Cardiovasc Med       Date:  2017-12-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.